Table 2.
Indicators of quality displayed quarterly, stratified for level of hospital, patients [%] treated as defined
| 2015 | 2016 | trend p-value | target value | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Q 1 | Q 2 | Q 3 | Q 4 | Q 1 | Q 2 | Q 3 | Q 4 | |||
| Early cerebral imaging (< 60 min after admission) in patients eligible for thrombolysis | 70 | |||||||||
| level-I | 47.8 | 40.9 | 60.0 | 48.3 | 54.6 | 67.7 | 60.7 | 60.0 | 0.0884 | |
| level-II/III | 75.1 | 73.3 | 75.5 | 71.9 | 72.9 | 71.1 | 70.6 | 66.0 | 0.0159 | |
| all levels | 72.9 | 70.5 | 74.3 | 69.5 | 70.3 | 70.7 | 69.5 | 65.3 | 0.0569 | |
| Door-to-needle-time < 60 min in patients with IVT | 90 | |||||||||
| level-I | 100.0 | 100.0 | 57.1 | 55.6 | 60.0 | 42.9 | 57.1 | 90.9 | 0.6475 | |
| level-II/III | 91.8 | 88.6 | 87.3 | 84.7 | 92.3 | 91.0 | 94.8 | 86.2 | 0.8483 | |
| all levels | 91.9 | 88.9 | 85.8 | 82.9 | 91.0 | 88.4 | 93.0 | 86.5 | 0.9491 | |
| Early intravenous thrombolysis (IVT) given in patients with indication for IVT | 35 | |||||||||
| level-I | 0.0 | 10.0 | 8.3 | 20.0 | 13.3 | 35.7 | 28.6 | 44.4 | 0.0015 | |
| level-II/-III | 40.9 | 43.1 | 47.3 | 39.7 | 40.5 | 45.6 | 45.7 | 41.8 | 0.7612 | |
| all levels | 38.9 | 40.8 | 44.3 | 37.9 | 37.5 | 44.8 | 44.1 | 42.1 | 0.4222 | |
| Platelet inhibitor given within 48 h in patients with IS or TIA | 95 | |||||||||
| level-I | 96.4 | 96.7 | 98.3 | 93.0 | 98.6 | 98.7 | 100.0 | 100.0 | 0.0295 | |
| level-II/III | 97.0 | 96.1 | 93.0 | 96.1 | 93.7 | 93.3 | 94.4 | 93.2 | 0.0074 | |
| all levels | 96.9 | 96.1 | 93.6 | 95.8 | 94.3 | 94.1 | 95.1 | 94.2 | 0.0543 | |
| Dysphagia screening | 90 | |||||||||
| level-I | 26.3 | 33.3 | 56.1 | 35.7 | 32.4 | 55.7 | 58.2 | 59.1 | <.0001 | |
| level-II/III | 95.6 | 97.9 | 96.6 | 95.0 | 98.1 | 97.5 | 96.2 | 96.0 | 0.9489 | |
| all levels | 91.5 | 92.6 | 92.9 | 90.0 | 90.8 | 93.7 | 91.6 | 92.4 | 0.7562 | |
| Early speech and language therapy for patients with dysphagia / dysphasia / dysarthria | 80 | |||||||||
| level-I | 63.2 | 58.6 | 85.0 | 65.4 | 61.8 | 97.0 | 72.3 | 73.2 | 0.2191 | |
| level-II/III | 95.9 | 98.2 | 92.0 | 96.0 | 97.6 | 96.3 | 96.3 | 95.2 | 0.9342 | |
| all levels | 94.2 | 94.9 | 91.2 | 93.7 | 93.8 | 96.4 | 93.2 | 92.7 | 0.8144 | |
| Early physio- / occupational therapy for patients with motor disability | 90 | |||||||||
| level-I | 66.7 | 76.9 | 90.3 | 95.2 | 82.1 | 87.5 | 97.5 | 84.2 | 0.0714 | |
| level-II/III | 97.8 | 97.8 | 97.1 | 98.6 | 97.4 | 98.8 | 96.3 | 97.4 | 0.5997 | |
| all levels | 96.4 | 95.7 | 96.3 | 98.3 | 96.0 | 97.4 | 96.5 | 95.7 | 0.9579 | |
| Early mobilisation of patients with severe disability | 90 | |||||||||
| level-I | 96.7 | 90.7 | 98.1 | 100.0 | 96.2 | 94.6 | 95.9 | 100.0 | 0.3319 | |
| level-II/III | 97.8 | 98.0 | 95.9 | 97.2 | 97.1 | 98.2 | 95.7 | 94.8 | 0.0216 | |
| all levels | 97.7 | 97.2 | 96.1 | 97.5 | 97.0 | 97.8 | 95.7 | 95.4 | 0.0645 | |
| Patients receiving an atrial fibrillation screening during their stay | 80 | |||||||||
| level-I | 87.5 | 88.4 | 93.3 | 91.4 | 91.0 | 88.3 | 88.3 | 96.3 | 0.2601 | |
| level-II/III | 92.1 | 93.0 | 92.3 | 92.8 | 94.0 | 92.8 | 94.9 | 94.1 | 0.0435 | |
| all levels | 91.8 | 92.4 | 92.5 | 92.6 | 93.6 | 92.2 | 94.0 | 94.4 | 0.0312 | |
| Extracranial carotid artery diagnostic in patients with IS or TIA | 80 | |||||||||
| level-I | 77.4 | 69.2 | 78.6 | 75.5 | 80.0 | 87.9 | 88.1 | 90.8 | <.0001 | |
| level-II/III | 92.4 | 94.9 | 94.1 | 95.8 | 96.7 | 95.7 | 94.5 | 95.0 | 0.0295 | |
| all levels | 91.4 | 92.0 | 92.3 | 93.8 | 94.5 | 94.7 | 93.6 | 94.4 | 0.0006 | |
| Revascularisation of symptomatic carotid stenosis in patients with IS or TIA | 60 | |||||||||
| level-I | 0.0 | 100.0 | – | – | 50.0 | 100.0 | 100.0 | 66.7 | 0.4174 | |
| level-II/III | 60.0 | 41.2 | 62.5 | 54.2 | 52.6 | 57.1 | 72.7 | 61.5 | 0.3310 | |
| all levels | 57.7 | 44.4 | 62.5 | 54.2 | 52.4 | 62.5 | 73.9 | 62.1 | 0.2315 | |
| Antihypertensive drugs at discharge in patients with IS or TIA | 95 | |||||||||
| level-I | 94.9 | 98.7 | 100.0 | 98.6 | 98.2 | 99.0 | 99.1 | 99.1 | 0.3111 | |
| level-II/III | 97.0 | 97.4 | 97.4 | 97.3 | 98.2 | 95.7 | 96.7 | 96.7 | 0.2404 | |
| all levels | 96.9 | 97.5 | 97.7 | 97.4 | 98.2 | 96.2 | 97.1 | 97.0 | 0.4743 | |
| Patients receiving statin at discharge or whom a statin was recommended | 80 | |||||||||
| level-I | 68.4 | 69.4 | 90.2 | 89.9 | 89.2 | 86.6 | 95.7 | 93.6 | <.0001 | |
| level-II/III | 71.5 | 79.7 | 77.4 | 76.9 | 80.3 | 78.8 | 79.8 | 77.6 | 0.0069 | |
| all levels | 71.3 | 78.5 | 78.8 | 78.2 | 81.5 | 79.8 | 82.0 | 79.7 | <.0001 | |
| Platelet inhibitor given at discharge in patients with IS or TIA and no anticoagulation | 95 | |||||||||
| level-I | 88.6 | 89.5 | 97.1 | 95.7 | 95.2 | 95.4 | 100.0 | 94.6 | 0.0302 | |
| level-II/III | 97.6 | 97.0 | 95.9 | 94.7 | 95.8 | 94.8 | 95.9 | 94.7 | 0.0101 | |
| all levels | 97.1 | 96.1 | 96.0 | 94.8 | 95.8 | 94.9 | 96.4 | 94.7 | 0.0101 | |
| Discharge in rehabilitation clinic | 70 | |||||||||
| level-I | 38.5 | 66.0 | 61.0 | 54.8 | 52.2 | 70.0 | 81.3 | 77.6 | 0.0005 | |
| level-II/III | 75.3 | 77.9 | 78.1 | 77.1 | 77.1 | 80.6 | 78.3 | 76.2 | 0.6075 | |
| all levels | 72.7 | 76.4 | 76.2 | 75.3 | 73.9 | 79.4 | 78.7 | 76.3 | 0.1302 | |